Search results

it didnt sound to me that the 809 isnt working....and the trial 770x809 has only just started, so there arent any results for that yet (770x809)...and we know that the 809 doesnt work by itself. It sounded like they're developing a second drug, 661, which is fantastic for df508ers!!! Your hopes...

it didnt sound to me that the 809 isnt working....and the trial 770x809 has only just started, so there arent any results for that yet (770x809)...and we know that the 809 doesnt work by itself. It sounded like they're developing a second drug, 661, which is fantastic for df508ers!!! Your hopes...

it didnt sound to me that the 809 isnt working....and the trial 770x809 has only just started, so there arent any results for that yet (770x809)...and we know that the 809 doesnt work by itself. It sounded like they're developing a second drug, 661, which is fantastic for df508ers!!! Your hopes...

I know from the 770 results that df508 people showed slight (clinically insignificant for validity)improvements in the sodium chloride channel...that tells me that the 770 does work for them (But not enough hence inclusion of 809), but also suggests that other genomes would react well to the 770...

I know from the 770 results that df508 people showed slight (clinically insignificant for validity)improvements in the sodium chloride channel...that tells me that the 770 does work for them (But not enough hence inclusion of 809), but also suggests that other genomes would react well to the 770...

I know from the 770 results that df508 people showed slight (clinically insignificant for validity)improvements in the sodium chloride channel...that tells me that the 770 does work for them (But not enough hence inclusion of 809), but also suggests that other genomes would react well to the 770...

I can tell you that everything you have read from the press releases is true, real and being experienced by the people on the drug.

I can tell you that everything you have read from the press releases is true, real and being experienced by the people on the drug.

I can tell you that everything you have read from the press releases is true, real and being experienced by the people on the drug.

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 I agree!! I really believe the combined 809x770 will have similar effects for df508....even the 770 had slight improvements with salt levels, indicating that it worked on some level, but not significantly. It's...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 I agree!! I really believe the combined 809x770 will have similar effects for df508....even the 770 had slight improvements with salt levels, indicating that it worked on some level, but not significantly. It's...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 I agree!! I really believe the combined 809x770 will have similar effects for df508....even the 770 had slight improvements with salt levels, indicating that it worked on some level, but not significantly. <br />...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 With a Specific Type of Cystic Fibrosis Showed Profound Improvements in Lung Function (FEV1) and Other Measures of Disease Through 24 Weeks > -Mean relative improvement in lung function of 17.4% and mean absolute...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 With a Specific Type of Cystic Fibrosis Showed Profound Improvements in Lung Function (FEV1) and Other Measures of Disease Through 24 Weeks > -Mean relative improvement in lung function of 17.4% and mean absolute...

> <br />> March 29, 2011 11:30 UTC <br />> <br />> Phase 3 Study of VX-770 in Children Ages 6 to 11 With a Specific Type of Cystic Fibrosis Showed Profound Improvements in Lung Function (FEV1) and Other Measures of Disease Through 24 Weeks <br />> -Mean relative improvement in lung function of...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 > > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 With a Specific Type of Cystic Fibrosis Showed Profound Improvements in Lung Function (FEV1) and Other Measures of Disease Through...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 > > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 With a Specific Type of Cystic Fibrosis Showed Profound Improvements in Lung Function (FEV1) and Other Measures of Disease Through...

> > March 29, 2011 11:30 UTC > > Phase 3 Study of VX-770 in Children Ages 6 to 11 > <br />> March 29, 2011 11:30 UTC <br />> <br />> Phase 3 Study of VX-770 in Children Ages 6 to 11 With a Specific Type of Cystic Fibrosis Showed Profound Improvements in Lung Function (FEV1) and Other Measures...

yes, you're right as usual Chris ;-)

yes, you're right as usual Chris ;-)